Palatin gets $95,000 research grant:
This article was originally published in Clinica
Executive Summary
US development-stage company Palatin Technologies has received a $95,000 small business innovation research grant from the US National Institutes of Health. The grant is to be used to develop a peptide-based nuclear medicine diagnostic tool to locate and image infection/inflammation sites in the body. The imaging technology is based on tuftsin, a tetrapeptide that is a component of the human immune system. Palatin is based in Princeton, New Jersey.